The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Aspirin as secondary prevention for colorectal cancer liver metastases (ASAC): A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial.
 
Sheraz Yaqub
Honoraria - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Bjørn Atle Bjørnbeth
No Relationships to Disclose
 
Jon-Helge Angelsen
No Relationships to Disclose
 
Richard Fristedt
Travel, Accommodations, Expenses - Medtronic
 
Claus Fristrup
Stock and Other Ownership Interests - Novo Nordisk
 
Oskar Hemmingsson
No Relationships to Disclose
 
Bengt Isaksson
No Relationships to Disclose
 
Ingebjørg Juel
No Relationships to Disclose
 
Anders Knudsen
Consulting or Advisory Role - AstraZeneca/Merck
Travel, Accommodations, Expenses - Covidien; Intuitive Surgical
 
Peter Larsen
Consulting or Advisory Role - Ferrosan Medical Devices
 
Kim Mortensen
No Relationships to Disclose
 
Inge Christoffer Olsen
Employment - Oslo University Hosptial
Consulting or Advisory Role - Dilafor AB
 
Per Sandstrom
No Relationships to Disclose
 
Oddvar Sandvik
No Relationships to Disclose
 
Ernesto Sparrelid
No Relationships to Disclose
 
Helena Taflin
Leadership - Isofol Medical
Stock and Other Ownership Interests - AstraZeneca/Merck; Isofol Medical; Xvivo
 
Morten Valberg
No Relationships to Disclose
 
Kjetil Tasken
Stock and Other Ownership Interests - Ledidi; Serca Pharmaceuticals
Consulting or Advisory Role - Serca Pharmaceuticals
Research Funding - AstraZeneca (Inst); GlaxoSmithKline (Inst); Illumina (Inst); Incyte (Inst); Johnson & Johnson/Janssen (Inst); Lilly (Inst); Merck KGaA (Inst); Novartis (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - Stock and Stock options, and royalty agreement through Oslo University Hospital / University of Oslo Tech Transfer Office Inven2 AS.
Travel, Accommodations, Expenses - Roche
 
The ASAC Study Group
No Relationships to Disclose